Skip to main content
. 2017 Nov 6;16(24):2326–2329. doi: 10.1080/15384101.2017.1388973

Figure 1.

Figure 1.

A schematic model illustrating how SPOP governs the BET protein stability and controls resistance to BET inhibitors. Prostate cancer cells with SPOP mutation exhibited increased resistance to BET inhibitor, where endometrial cancer-associated SPOP mutants lead to sensitization to BET inhibitors in endometrial cancer.